---
figid: PMC5908125__JCMM-22-2865-g009
figtitle: 'Glyoxalase 1 (Glo1) sustains the metastatic phenotype of prostate cancer
  cells via epithelial‐to‐mesenchymal transition (EMT) control: involvement of miR‐101,
  hydroimidazolone (MG‐H1), argpyrimidine (AP) and TGF‐B1/Smads signalling pathway'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Armoracia rusticana
- Chondrosia corticata
organisms_ner:
- Rattus norvegicus
- Bos taurus
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC5908125
filename: JCMM-22-2865-g009.jpg
figlink: /pmc/articles/PMC5908125/figure/jcmm13581-fig-0009/
number: F9
caption: 'Glyoxalase 1 (Glo1) sustains the metastatic phenotype of prostate cancer
  cells via epithelial‐to‐mesenchymal transition (EMT) control: involvement of miR‐101,
  hydroimidazolone (MG‐H1), argpyrimidine (AP) and TGF‐β1/Smads signalling pathway.
  Glo1 up‐regulation, maintained by the decreased expression (X mark) of the tumour
  suppressor miR‐101, leads to MG‐H1‐AP depletion. In turn, MG‐H1‐AP depletion contributes
  to keep activated TGF‐β1/Smads signalling pathway that promotes EMT by inhibiting
  the epithelial markers E‐cadherin (E‐cad) and zonula occludens‐ (ZO‐1) and activating
  the mesenchymal markers vimentin (Vim) and N‐cadherin (N‐cad), together with MMP‐2
  and MMP‐9, directly via Snail and/or indirectly via other TGF‐β1/Smad‐dependent
  EMT‐associated transcription factors. Altogether, these events sustain the invasive
  and migrating metastatic phenotype of prostate cancer cells'
papertitle: Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells
  via EMT control.
reftext: Cinzia Antognelli, et al. J Cell Mol Med. 2018 May;22(5):2865-2883.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.902622
figid_alias: PMC5908125__F9
figtype: Figure
redirect_from: /figures/PMC5908125__F9
ndex: 6df0ee1f-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5908125__JCMM-22-2865-g009.html
  '@type': Dataset
  description: 'Glyoxalase 1 (Glo1) sustains the metastatic phenotype of prostate
    cancer cells via epithelial‐to‐mesenchymal transition (EMT) control: involvement
    of miR‐101, hydroimidazolone (MG‐H1), argpyrimidine (AP) and TGF‐β1/Smads signalling
    pathway. Glo1 up‐regulation, maintained by the decreased expression (X mark) of
    the tumour suppressor miR‐101, leads to MG‐H1‐AP depletion. In turn, MG‐H1‐AP
    depletion contributes to keep activated TGF‐β1/Smads signalling pathway that promotes
    EMT by inhibiting the epithelial markers E‐cadherin (E‐cad) and zonula occludens‐
    (ZO‐1) and activating the mesenchymal markers vimentin (Vim) and N‐cadherin (N‐cad),
    together with MMP‐2 and MMP‐9, directly via Snail and/or indirectly via other
    TGF‐β1/Smad‐dependent EMT‐associated transcription factors. Altogether, these
    events sustain the invasive and migrating metastatic phenotype of prostate cancer
    cells'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Tgfbr1
  - Glo1
  - Smad2
  - Snai1
  - Smad3
  - Smad4
  - Tjp1
  - Vim
  - Mmp2
  - Mmp9
  - Slc22a3
  - MIR101-2
  - GLO1
  - SMAD2
  - SNAI1
  - SMAD3
  - SMAD4
  - TJP1
  - VIM
  - MMP2
  - MMP9
  - Ltbp1
  - Tgfbr2
  - Mir101a
  - Cdh1
  - Cdh2
  - Itk
  - ap
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - TGFBR2
  - CDH1
  - CDH2
  - ITK
  - SLC22A3
  - glo1
  - smad2
  - snai1a
  - smad3a
  - smad4a
  - smad4b
  - vim
  - mmp2
  - cdh2
  - mmp9
  - hoxa5a
---
